Essay
Published essay on Faeth Therapeutics' journey from seed investment to public markets, reflecting on founder resilience and long-term stewardship.
From a Seed Check to Nasdaq
FEB 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
From a Seed Check to Nasdaq
Faeth Therapeutics
TextQL
Alexis Zamira Maciel promoted to Principal